The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. My name is Rochelle, and I will be your ...

Learn the early warning signs of esophageal cancer that are often missed. Discover risk factors, treatment options and how to ...

Gastric cancer, as it is known medically, affects more men than women and is more common in older people. About six of every ...

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...

Early signs of stomach cancer often resemble those of more common digestive issues, such as indigestion and heartburn.